Myeloproliferative Disorders

• CLINICAL_TRIALS research · 2026-03-03
  Clinical Trial Update: Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) [NA]

  A hematology-focused clinical trial update for HEM-Profiling 2021, currently recruiting to explore chemogenomic profiling across multiple le…

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: Pathogenesis of Hematologic Malignancies

  An update on an ongoing clinical trial exploring the pathogenesis of hematologic malignancies, with enrollment by invitation at the sponsor …

• CLINICAL_TRIALS research · 2026-01-02
  Clinical Trial Update: Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation [Phase 1]

  Phase 1 clinical trial evaluating preemptive CIML NK cell therapy after hematopoietic stem cell transplantation in patients with acute myelo…

• CLINICAL_TRIALS research · 2025-06-25
  Clinical Trial Update: Registry of Older Patients With Cancer

  This clinical trial registry entry from UNC Lineberger indicates an ongoing recruitment for a registry of older patients with cancer, includ…

• CLINICAL_TRIALS research · 2017-05-09
  Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT

  This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2014-12-03
  Clinical Trial Update: Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2, Phase 3]

  Clinical trial update for a Phase 2/Phase 3 study evaluating plasmatic levels of busulfan in patients undergoing hematopoietic stem cell tra…

• CLINICAL_TRIALS research · 2013-02-20
  Clinical Trial Update: Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer [Phase 1, Phase 2]

  A completed Phase 1/2 clinical trial evaluating infusion of donor-derived natural killer cells after donor stem cell transplant for various …

• CLINICAL_TRIALS research · 2011-03-07
  Clinical Trial Update: Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

  This update notes termination of a clinical trial evaluating an immunologic diagnostic blood test intended to predict donor stem cell transp…

• CLINICAL_TRIALS research · 2009-09-15
  Clinical Trial Update: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias [Phase 2]

  This entry outlines a Phase 2 study evaluating imatinib (STI571) in patients with hypereosinophilic syndrome and eosinophilic leukemias, wit…